Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a close family member (parent, sibling, or child), living or deceased, who has been diagnosed with or probably had Alzheimer's disease that developed later in life
- People who have noticed changes in their own memory and are concerned about those changes
- People who score 26 or higher on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA)
- People who are willing to give their formal agreement to take part in the study
- People who are able to follow the treatment schedule throughout the study
- People whose medications have been the same for at least 2 months and are not expected to change during the study (if taking any medications)
- People who pass a safety screening questionnaire related to the treatment used in this trial (a type of brain stimulation called TMS)
- People who have a family member, friend, or carer who is able to fill in questionnaires about the participant during the study
Who may not be able to join:
- People who have any metal implants in their head (outside the mouth), such as ear implants, brain stimulators, or aneurysm clips
- People who have, or have had, increased pressure in the brain, which may raise the risk of seizures
- People who have a cardiac pacemaker
- People who have an implanted medication pump
- People who have a central venous line (a type of tube inserted into a large vein)
- People who have a significant heart condition
- People who currently have depression, or have a history of certain mental health conditions including psychotic disorders, bipolar disorder, eating disorders, obsessive compulsive disorder, post-traumatic stress disorder, or a type of dementia other than Alzheimer's disease
- People who have used alcohol or drugs problematically in the last 6 months
- People who have had a stroke or have other known lesions (areas of damage) in the brain
- People who have a personal history of epilepsy
- People who have a family history of epilepsy
- Women who are pregnant or breastfeeding
- People who have had an abnormal brain MRI scan
- People who have significant hearing loss that requires hearing aids
- People who have an untreated thyroid condition (either underactive or overactive thyroid)
- People who have other reasons they cannot safely receive TMS (confirm with trial site)
- People who have unstable medical conditions
- People who have regularly used benzodiazepines (a type of sedative or anxiety medication) or other sleep medications within 2 weeks of being enrolled in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Linda Mah, Baycrest Rotman Research Institute
Phone: 416-785-2500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of scheduled treatment sessions that are attended by study participants
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.